Asthma
Pulmonology
Neonatology
Children with Chronic Conditions
General Pediatrics
Cross-Disciplinary Pathway
Clinical Research Pathway
Allergy, Immunology and Rheumatology
Paul Moore, MD
Professor of Pediatrics
Pediatrics
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Rita Ryan, MD
Professor of Pediatrics
Pediatrics
Case Western Reserve University
Cleveland, Ohio, United States
Bronchpulmonary dysplasia (BPD) has been used for over 30 years as a predictor of early respiratory morbidity, but increased survival of extremely low gestational age newborns (ELGANs) and changes in NICU practice have resulted in limitations to BPD as a predictive value. The Premature Respiratory Outcomes Program (PROP) and Trial of Late Surfactant for Prevention of BPD (TOLSURF) Study are NIH-funded longitudinal birth cohorts of ELGANs that have provided a wealth of clinical, biochemical, and genetic data to study the association of preterm birth with respiratory morbidity. This session hopes to provide clinicians from Neonatology, General Pediatrics, and Pulmonology with an update on predictors of respiratory morbidity in preterm children.
Presenter: Judy L. Aschner, MD – Joseph M Sanzari Children's Hospital at Hackensack Meridian Health
Presenter: Andrew Dylag, MD – University of Rochester
Presenter: James Kemp, Medical Doctor – Washington University in St. Louis
Presenter: Dara G. Torgerson, PhD – University of California San Francisco
Presenter: Kristin Scheible, MD – University of Rochester
Presenter: Roberta Keller, MD – University of California San Francisco
Presenter: -- --
Presenter: -- --